Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: neurodegenerative diseases

May 25, 2026 CD as API / Pharma applications

CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation

This review critically examines how cyclodextrins modulate regulated cell death pathways and the implications for immunometabolism and therapeutic translation. Increasing

Continue reading

November 6, 2024 CD as API / Pharma applications

More and more manipulated results in Alzheimer and Parkinson’s research

 „Short road to discovery, winding road to use”                                                                                                 Josef Pitha I assume that many of you remember the “story”

Continue reading

January 15, 2024 CD as API / Drug delivery / Pharma applications

Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans

The elevated occurrence of debilitating neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), Alzheimer’s disease (AD), Parkinson’s

Continue reading

December 5, 2023 CD as API / Pharma applications

Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases

This work presents the most recent advances in the research and clinical use of HPβCD against Niemann–Pick disease, a congenital

Continue reading

November 22, 2021 Uncategorized

Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

A patent application by Knut M. Wittkowski (ASDERA LLC, US) entitled “Use of cyclodextrins in diseases and disorders involving phospholipid

Continue reading

Recent Posts

  • CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation
  • Nanotechnology World Conference 2026
  • Hybrid Cyclodextrin Nanosponges Meet Nanoporous Gold: A Step Forward in Sensing Platforms
  • Innovative Cyclodextrin Composition for Canine Odour Neutralization
  • Cyclodextrin and its derivatives for the structural regulation of epoxy resins: Chemistry, mechanisms, and emerging applications

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (66)
  • CD as API (345)
  • CD derivatives (407)
  • Cosmetics and toilettry (50)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (221)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (397)
  • Other industrial use (106)
  • Pharma applications (1,175)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation
  • HPBCD can cross the Brain-Blood Barrier
  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin and its derivatives for the structural regulation of epoxy resins: Chemistry, mechanisms, and emerging applications
  • Lanosterol eye drops for cataract treatment
  • Improving Drug Bioavailability with Cyclodextrin Complexes: An integrative meta-modeling approach
  • The story of cyclodextrin metal–organic frameworks and their applications from Nobel-prize laureate, F. Stoddart
  • Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
  • Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition
  • MIT scientists filed patent for HPBCD treatment in Alzheimer's disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers

Loading Comments...